Nova Patents
PL3677275T3

Combination of an insulin and a glp-1 agonist

Abstract

This record has no abstract on file.

Term

3 yearsto projected expiry

Projected expiry 9 October 2029, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

100 members in 41 offices

This recordMember, by publication datePriority claim31 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
102008051834GermanyA
102008053048GermanyA
102009038210GermanyA

Members100

Family members, oldest first
DocumentOfficeKind
AU2009305472A1AustraliaA1
CA2740685A1CanadaA1
CA3016451A1CanadaA1
DE102008051834A1GermanyA1
WO2010043566A2World Intellectual Property Organization (WIPO)A2
DE102008053048A1GermanyA1
PA8845901A1PanamaA1
UY32183AUruguayA
WO2010043566A3World Intellectual Property Organization (WIPO)A3
TW201026321ATaiwan Province of ChinaA
AR073872A1ArgentinaA1
DE102009038210A1GermanyA1
MX2011003804AMexicoA
DOP2011000104ADominican RepublicA
ECSP11010986AEcuadorA
IL212258A0IsraelA0
IL212258D0IsraelD0
CR20110188ACosta RicaA
KR20110084956ARepublic of KoreaA
EP2349324A2European Patent Office (EPO)A2
MA32703B1MoroccoB1
NI201100068ANicaraguaA
CN102256618AChinaA
CO6361944A2ColombiaA2
US2012021978A1United States of AmericaA1
PE20120060A1PeruA1
JP2012505852AJapanA
CL2011000851A1ChileA1
ZA201102400BSouth AfricaB
NZ592283ANew ZealandA
RU2011119639ARussian FederationA
TN2011000160A1TunisiaA1
JP2012255040AJapanA
AU2009305472B2AustraliaB2
CN103736082AChinaA
UA106478C2UkraineC2
RU2532378C2Russian FederationC2
JP5731981B2JapanB2
JP5732016B2JapanB2
HN2011001021AHondurasA
TWI494121BTaiwan Province of ChinaB
RU2014132563ARussian FederationA
CN105396126AChinaA
KR20160107351ARepublic of KoreaA
MX344293BMexicoB
US9526764B2United States of AmericaB2
HK1222568AHong Kong, ChinaA
HK1222568A1Hong Kong, ChinaA1
MX349717BMexicoB
EP2349324B1European Patent Office (EPO)B1
BRPI0920881A2BrazilA2
IL212258AIsraelA
US2017281733A1United States of AmericaA1
EP3228320A1European Patent Office (EPO)A1
CR20170369ACosta RicaA
IL254465A0IsraelA0
IL254465D0IsraelD0
PT2349324TPortugalT
DK2349324T3DenmarkT3
LT2349324TLithuaniaT
KR101820024B1Republic of KoreaB1
ES2650621T3SpainT3
KR20180008906ARepublic of KoreaA
HRP20171894T1CroatiaT1
SI2349324T1SloveniaT1
PL2349324T3PolandT3
RS56632B1SerbiaB1
HK1244701AHong Kong, ChinaA
HK1244701A1Hong Kong, ChinaA1
HUE037449T2HungaryT2
CA2740685CCanadaC
BR122013025625A2BrazilA2
US10117909B2United States of AmericaB2
CY1119952T1CyprusT1
KR101939557B1Republic of KoreaB1
RU2682671C2Russian FederationC2
IL254465AIsraelA
IL254465BIsraelB
US2019192635A1United States of AmericaA1
EP3228320B1European Patent Office (EPO)B1
DK3228320T3DenmarkT3
LT3228320TLithuaniaT
PT3228320TPortugalT
RS59913B1SerbiaB1
SI3228320T1SloveniaT1
PL3228320T3PolandT3
HRP20200340T1CroatiaT1
EP3677275A1European Patent Office (EPO)A1
ES2772731T3SpainT3
HUE048608T2HungaryT2
BR122013025625B1BrazilB1
BRPI0920881B1BrazilB1
US2022016217A1United States of AmericaA1
US2024108692A1United States of AmericaA1
EP3677275B1European Patent Office (EPO)B1
PT3677275TPortugalT
PL3677275T3This recordPolandT3
ES2992698T3SpainT3
HUE068164T2HungaryT2
US2025161416A1United States of AmericaA1